LivaNova (LIVN) Return on Capital Employed Growth (5y) (2021 - 2026)
LivaNova (LIVN) Return on Capital Employed Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,778.00 |
| Mar 31, 2026 | 2,404.00 |
| Dec 31, 2025 | 2,397.00 |
| Sep 30, 2025 | 1,894.00 |
| Jun 30, 2025 | 1,642.00 |
| Mar 31, 2025 | 1,682.00 |
| Dec 31, 2024 | 1,475.00 |
| Sep 30, 2024 | 1,467.00 |
| Jun 30, 2024 | 1,452.00 |
| Mar 31, 2024 | 1,205.00 |
| Dec 31, 2023 | 856.00 |
| Sep 30, 2023 | -46.00 |
| Jun 30, 2023 | -871.00 |
| Mar 31, 2023 | -864.00 |
| Dec 31, 2022 | -842.00 |
| Sep 30, 2022 | -615.00 |
| Jun 30, 2022 | 91.00 |
| Mar 31, 2022 | -224.00 |
| Dec 31, 2021 | -157.00 |
| Sep 30, 2021 | -1,764.00 |